Health TrialsbyHealthPanel

Erector Spinae Block vs Conventional Analgesia for Postoperative Analgesia in PCNL

ConditionPercutaneous Nephrolithotomy (PCNL)
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-60
SponsorSohag University

About this trial

50 adult patients scheduled for percutaneous nephrolithotomy in Sohag university hospitals will be devided in two groups one of them will receive Sonographic guided erector spinae plane block using 20 ml volume of bupivacaine 0.25 percent and the other will receive conventional analgesia of 0.1 mg/kg IV morphine

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

ASA 1 to ASA 2 18 to 60 years

Disqualifiers

patient refusal Significant neurological , psychiatric or neuromascular disease Drug abuse Pregnant or lactating women Suspected coagulopathy Morbid obesity Known allergy to some medications Septicaemia and local infection at block site

Trial design

Design model

Parallel

Treatments tested in this trial

  • Sonographic guided Erector spinae plane block

    Procedure/Surgery

    Ultrasound guided plane block using 20 ml of 0.25% bupivacaine at the level of transverse process of T8

  • Intravenous opioid

    Drug

    0.1 mg/kg morphine intravenous pre operative

Treatment groups

50 Participants
are divided into 2 treatment groups
Group A: Erector spinae plane block groupActive comparator 1 intervention
Group B: Conventional analgesia groupActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Reduction of postoperative pain

VAS score for pain measurement

Time frame
1 year

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Sohag University

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: